Company intelligence / Profile preview
Herantis Pharma
Helsinki, Finlandherantis.com ↗
- Ownership
- Public · HRTIS
- Employees
- ~10
- Development stage
- Phase 1
01
Overview
Herantis’ lead product, HER‑096, has completed Phase 1a with positive safety and tolerability results in healthy volunteers. The ongoing Phase 1b trial in Parkinson’s patients aims to demonstrate safety and tolerability of repeated subcutaneous doses. Pharmacokinetic data show efficient blood-brain barrier penetration and CSF concentrations within the predicted active range. Topline data from the patient cohort are expected Q3 2025[6][9][10].
- Therapeutic areas
- Neurology
- Modalities
- small synthetic peptides/peptidomimetics
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Long-term collaboration with Medfiles for clinical trial operations since 2009[3].Contract Research Services Turku – CRST Oy runs current clinical trials[9].No major pharma partnerships disclosed.
Beyond the preview
Go deeper on Herantis Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Herantis Pharma.